The guidance recommendations cover four main areas: Whether and how to use EHRs as a source of data, using EHRs that are interoperable with electronic systems supporting clinical investigations, ensuring the quality and integrity of EHR data used, and ensuring the EHR data collected and used meets FDA requirements.
Using EHRs in clinical trials can help modernize and streamline such investigations, according to the guidance.
The guidance is still in draft form, and the FDA seeks comments and suggestions on the document. To read the guidance, click here.
More articles on EHRs:
38% of execs want telemedicine programs built onto their EHRs & 6 other survey takeaways
Can EHRs predict flu outbreaks?
Just 2 in 10 consumers use EHR data to make medical decisions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.